Hypocholesterolemic effects of diets containing different levels of kishk as a dried fermented milk–whole wheat mixture in experimental rats

Journal of Ethnic Foods

Volumn 3, Issue 2, 2016, Pages 117-123

  Ali, Rehab F M ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

biochemical; function food; hypercholesterolemia; kishk; whole wheat

Indexed keywords

EID: 84990046521     PISSN: None     EISSN: 23526181     Source Type: Journal    
DOI: 10.1016/j.jef.2016.01.009     Document Type: Article

References (87)

1. [1] Durrington, P., Dyslipidaemia, review. Lancet 362 (2003), 717–731.
2. [2] Napoli, C., Crudele, V., Soricelli, A., Al-Omran, M., Vitale, N., Infante, T., Mancini, F.P., Primary prevention of atherosclerosis: a clinical challenge for the reversal of epigenetic mechanisms?. Circulation 125 (2012), 2363–2373.
3. [3] Kannel, W.B., Castelli, W.P., Gordon, T., McNamara, P.M., Serum cholesterol, lipoproteins, and the risk of coronary heart disease. Ann Intern Med 74 (1971), 1–12.
4. [4] Ross, R., Harker, L., Hyperlipidemia and atherosclerosis. Science 193 (1976), 1094–1100.
5. [5] Grundy, S.M., Low-density lipoprotein, non-high-density lipoprotein, and apolipoprotein B as targets of lipid-lowering therapy. Circulation 106 (2002), 2526–2529.
6. [6] Frost, P.H., Havel, R.J., Rationale for use of non-high-density lipoprotein cholesterol rather than low-density lipoprotein cholesterol as a tool for lipoprotein cholesterol screening and assessment of risk and therapy. Am J Cardiol 81 (1998), 26B–31B.
7. [7] Stacy, T.A., Egger, A., Results of retrospective chart review to determine improvement in lipid goal attainment in patients treated by high-volume prescribers of lipid-modifying drugs. J Manag Care Pharm 12 (2006), 745–751.
8. [8] Ray, K.K., Cannon, C.P., Ganz, P., Beyond lipid lowering: what have we learned about the benefits of statins from the acute coronary syndromes trials?. Am J Cardiol 98 (2006), 18P–25P.
9. [9] Khush, K.K., Waters, D.D., Effects of statin therapy on the development and progression of heart failure: mechanisms and clinical trials. J Card Fail 12 (2006), 664–674.
10. [10] Clearfield, M., Statins and the primary prevention of cardiovascular events. Curr Atheroscler Rep 8 (2006), 390–396.
11. [11] Talbert, R.L., Safety issues with statin therapy. J Am Pharm Assoc 46 (2003), 479–488.
12. [12] Parra, J.L., Reddy, K.R., Hepatotoxicity of hypolipidemic drugs. Clin Liver Dis 7 (2003), 415–433.
13. [13] Trifiro, G., Drug–drug interactions and statin therapy. South Med J 99 (2006), 1325–1326.
14. [14] Neuvonen, P.J., Niemi, M., Backman, J.T., Drug interactions with lipid lowering drugs: mechanisms and clinical relevance. Clin Pharmacol Ther 80 (2006), 565–581.
15. [15] Kiortsis, D.N., Filippatos, T.D., Mikhailidis, D.P., Elisaf, M.S., Liberopoulos, E.N., Statin-associated adverse effects beyond muscle and liver toxicity. Atherosclerosis 195 (2007), 7–16.
16. [16] Kojuri, J., Vosoughi, A., Akrami, M., Effects of anethum graveolens and garlic on lipid profile in hyperlipidemic patients. Lipids Health Dis, 6, 2007, 5.
17. [17] Yangilar, F., The application of dietary fibre in food industry: structural features, effects on health and definition, obtaining and analysis of dietary fibre: a review. J Food Nutr Res 1 (2013), 13–23.
18. [18] Lambert, N., Diet, phytochemicals and cancer. Frewer, L.J., Schifferstein, R., Risvik, E., (eds.) Food choice in Europe. Munich (Germany), 2001, Springer-Verlag, 131–151.
19. [19] Ibanoglu, S., Ibanoglu, E., Ainsworth, P., The effect of different ingredients on the fermentation activity in tarhana. Food Chem 64 (1999), 103–106.
20. [20] Abd-el-Malek, Y., Demerdash, M., Egyptian kishk. Steinkraus, K.H., (eds.) Handbook of indigenous fermented foods, 1993, Marcel Dekker, New York (NY), 295–299.
21. [21] Mahmoud, S.A.Z., Egyptian kishk. Steinkraus, K.H., (eds.) Handbook of indigenous fermented foods, 1993, Marcel Dekker, New York (NY), 295–299.
22. [22] Morcos, S.R., Hegazi, S.M., Ell-Damhougy, S.I.T., Egyptian bouza. Steinkraus, K.H., (eds.) Handbook of indigenous fermented foods, 1993, Marcel Dekker, New York (NY), 421–425.
23. [23] Odunfa, S.A., Oyewole, O.B., African fermented foods. Woods, J.B., (eds.) Microbiology of fermented foods, 1998, Blackie Academic and Professional, London (UK), 713–752.
24. [24] AOAC, Official methods of analysis of association of official analytical chemists. 17th ed., 2000, AOAC, Washington (DC).
25. [25] Reeves, G.P., Nielsen, H.F., Fahey, C.G., AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition Ad Hoc Writing Committee on the reformulation of the AIN-76A rodent diet. J Nutr 123 (1993), 1939–1951.
26. [26] Roeschlau, P., Bernt, E., Gruber, W.L., Kinetics of the cholesterol–sulfuric acid reaction. A fast kinetic method for serum cholesterol. Clin Chem Clin Biochem 12 (1974), 403–408.
27. [27] Assmann, G., Cholesterol determination in high density lipoproteins separated by three different methods. Internist 20 (1979), 559–604.
28. [28] Levy, R.I., Cholesterol, lipoproteins, apoproteins, and heart disease: present status and future prospects. Clin Chem, 27, 1981, 653.
29. [29] Fossati, P., Prencipe, I., The determination of triglyceride using enzymatic methods. Clin Chem 28 (1982), 2077–2080.
30. [30] Hostmark, A.T., Berg, J.E., Osland, A., Simonsen, S., Vantne, K., Lipoprotein-related coronary risk factor in patients with angiographically defined coronary artery disease and control: improved group separation by indexes reflecting the balance between low and high density lipoprotein. Coron Artery Dis 2 (1991), 679–684.
31. [31] Kim, D.H., Sho, K.S., Experimental study of Pinus densiflora et zuccarini on hyperlipidemia and lipid in rats. KPI 10 (2007), 109–119.
32. [32] Bergmeyer, H.U., Harder, M., A colorimetric method of determination of serum glutamic oxaloacetic and pyruvic transaminase. Clin Biochem 24 (1986), 28–34.
33. [33] Fawcett, J.K., Scott, J.E., Enzymatic, colorimetric method for determination urea in serum, plasma and urine. J Clin Pathol 13 (1960), 156–162.
34. [34] Barham, D., Trinder, P., Enzymatic, colorimetric method for determination uric acid in serum plasma and urine. Analyst 97 (1972), 142–146.
35. [35] Bartles, H., Bohmer, M., Heierli, C., Serum creatinine determination without protein precipitation. Clin Chim Acta 37 (1972), 193–197.
36. [36] Gomez, K.A., Gomez, A.A., Statistical procedures for agricultural research. 1984, John Wiley & Sons, Inc., New York (NY).
37. [37] Grundy, S.M., Denke, M.A., Dietary influences on serum lipids and lipoproteins. J Lipid Res 36 (1990), 1277–1282.
38. [38] Bazzano, L.A., Song, Y., Bubes, V., Good, C.K., Manson, J.E., Liu, S., Dietary intake of whole and refined breakfast cereals and weight gain in men. Obes Res 13 (2005), 1952–1960.
39. [39] Lindstrom, J., Peltonen, M., Eriksson, J.G., Louheranta, A., Fogelholm, M., Uusitupa, M., Tuomilehto, J., High-fibre, low fat diet predicts long term weight loss and decreased type 2 diabetes risk: the Finnish Diabetes Prevention Study. Diabetologia 49 (2006), 912–920.
40. [40] Fernandez, M.L., Sun, D.M., Tosca, M.A., McNamara, D.J., Citrus pectin and cholesterol interact to regulate hepatic cholesterol homeostasis and lipoprotein metabolism: a dose-response study in guinea pigs. Am J Clin Nutr 59 (1994), 869–878.
41. [41] Delzenne, N.M., Cani, P.D., Daubioul, C., Neyrinck, A.M., Impact of inulin and oligofructose on gastrointestinal peptides. Br J Nutr 93 (2005), S157–S161.
42. [42] Gaysinskaya, V.A., Karatayev, O., Chang, G.Q., Leibowitz, S.F., Increased caloric intake after a high-fat preload: relation to circulating triglycerides and orexigenic peptides. Physiol Behav 91 (2007), 142–153.
43. [43] Stevens, K.R., Gallo, M.A., Practical considerations in the conduct of chronic toxicity studies. Hayes, A.W., (eds.) Principles and methods of toxicology, 1989, Raven Press, New York (NY), 237–250.
44. [44] Jemai, H., Fki, I., Bouaziz, M., Bouallagui, Z., El Feki, A., Isoda, H., Sayadi, S., Lipid-lowering and antioxidant effects of hydroxytyrosol and its triacetylated derivative recovered from olive tree leaves in cholesterol-fed rats. J Agric Food Chem 56 (2008), 2630–2636.
45. [45] Osfor, M.M.H., Hegazy, A., El-moaty, M.A., Elmadbouly, M.A., Afify, R.A.M., Elbahnasawy, A.S.M., Hypo-cholesterolemic and hypoglycemic effects of orange albedo powder (Citrus aurantium L.) on male albino rats. Int J Nutr Food Sci 2 (2013), 70–76.
46. [46] Bazzano, L.A., Thompson, A.M., Tees, M.T., Nguyen, C.H., Winham, D.M., Non-soy legume consumption lowers cholesterol levels: a meta analysis of randomized controlled trials. Nutr Metab Cardiovasc Dis 21:2 (2011 Feb), 94–103.
47. [47] Gould, A.L., Rossouw, J.E., Santanello, N.C., Heyse, J.F., Furberg, C.D., Cholesterol reduction yields clinical benefit—a new look at old data. Circulation 91 (1995), 2274–2282.
48. [48] Berliner, J.A., Heinecke, J.W., The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med 20 (1996), 707–727.
49. [49] Dean, R., Fu, S., Stocker, R., Davies, M.J., Biochemistry and pathology of radical-mediated protein oxidation. Biochem J 324 (1997), 1–18.
50. [50] Jenkins, J.A.D., Kendall, C.W.C., Vuksan, V., Augstin, L.S.A., Mehling, C., Parker, T., Vidgen, E., Lee, B., Faulkner, D., Seyler, M., Josse, R., Leiter, L.A., Connelly, P.W., Fulgoni, V., Effect of wheat bran on serum lipids: influence of particle size and wheat protein. Am J Clin Nutr 2 (1999), 159–165.
51. [51] Chen, W.J., Anderson, J.W., Jennings, D., Propionate may mediate the hypocholesterolemic effects of certain soluble plant fibers in cholesterol-fed rats. Proc Soc Exp Biol Med 175 (1984), 215–218.
52. [52] Cook, S.I., Sellin, J.H., Short chain fatty acids in health and disease. Aliment Pharmacol Ther 12 (1998), 499–507.
53. [53] Thacker, P.A., Salamons, M.O., Aherne, F.X., Influence of propionic acid on the cholesterol metabolism of pigs fed hypercholesterolemic diets. Can J Anim Sci 61 (1981), 969–975.
54. [54] Jeong, H.J., Park, S.B., Kim, S., Kim, H.K., Total polyphenol content and antioxidative activity of wild grape (Vitis coignetiae) extracts depending on ethanol concentrations. J Korean Soc Food Sci Nutr 36 (2007), 1491–1496.
55. [55] Mälkki, Y., Oat fiber. Production, composition, physicochemical properties, physiological effects, safety, and food applications. Cho, S.S., Dreher, M.L., (eds.) Handbook of dietary fiber, 2001, Marcel Dekker, Inc, New York pp. 497–517.
56. [56] Martin-Sosa, S., Martin, M.J., Hueso, P., The sialylated fraction of milk oligosaccharides is partially responsible for binding to enterotoxigenic and uropathogenic Escherichia coli human strains. J Nutr 132 (2002), 3067–3072.
57. [57] Ha, C.G., Cho, J.K., Lee, C.H., Chai, Y.G., Ha, Y.A., Shin, S.H., Cholesterol lowering effect of Lactobacillus plantarum isolated from human feces. J Microbiol Biotechnol 16 (2006), 1201–1209.
58. [58] Gilliland, S.E., Nelson, C.R., Maxwell, C., Assimilation of cholesterol by Lactobacillus acidophilus. Appl Environ Microbiol 49 (1985), 377–381.
59. [59] Akalin, A., Gönc, S., Düzel, G., Influence of yogurt and acidophilus yogurt on serum cholesterol levels in mice. J Dairy Sci 80 (1997), 2721–2725.
60. [60] Danielson, A.D., Peo, E.R., Shahani, K.M. Jr., Lewis, A.J., Whalen, P.J., Amer, M.A., Anticholesteremic property of Lactobacillus acidophilus yogurt fed to mature boars. J Anim Sci 67 (1989), 966–974.
61. [61] Grunewald, K.K., Serum cholesterol levels in rats fed skim milk fermented with Lactobacillus acidophilus. J Food Sci 47 (1982), 2078–2079.
62. [62] Jin, L.Z., Ho, Y.W., Abdullah, N., Jalaludin, S., Growth performance, intestinal microbial populations, and serum cholesterol of broilers fed diets containing Lactobacillus cultures. Poult Sci 77 (1998), 1259–1265.
63. [63] de Rodas, B.Z., Gilliland, S.E., Maxwell, C.V., Hypocholesterolemic action of Lactobacillus acidophilus and calcium in diet induced hypercholesterolemic swine. J Dairy Sci 79 (1996), 2121–2128.
64. [64] Begley, M., Hill, C., Gahan, C.G.M., Bile salt hydrolase activity in probiotics. Appl Environ Microbiol 72 (2006), 1729–1738.
65. [65] Jones, M.L., Chen, H., Ouyang, W., Metz, T., Prakash, S., Microencapsulated genetically engineered Lactobacillus plantarum 80 (pCBH1) for bile acid deconjugation and its implication in lowering cholesterol. J Biomed Biotechnol 1 (2004), 61–69.
66. [66] Roy, S., Freake, H.C., Fernandez, M.L., Gender and hormonal status affect the regulation of hepatic cholesterol alpha-hydroxylase activity and mRNA abundance by dietary soluble fiber in the guinea pig. Atherosclerosis 163 (2002), 29–37.
67. [67] Shali, P.K., Kaul, S., Nilsson, J., Cercek, B., Exploiting the vascular protective effects of high-density lipoprotein and its apolipoproteins: an idea whose time for testing is coming. Circulation 104 (2001), 2376–2383.
68. [68] Assmann, G., Nofer, J., Atheroprotective effects of high-density lipoproteins. Annu Rev Med 54 (2003), 321–341.
69. [69] Mun, S., Decker, E.A., Park, Y., Weiss, J., McClements, D.J., Influence of interfacial composition on in vitro digestibility of emulsified lipids: potential mechanism for chitosan's ability to inhibit fat digestion. Food Biophys 1 (2006), 21–29.
70. [70] Herman-Lara, E., Elvira-Torales, L.I., Rodriguez-Miranda, J., Torruco-Uco, J.G., Carmona-García, R., Mendoza-García, P.G., García, H.S., Soto-Rodríguez, I., Impact of micronized starfruit (Averrhoa carambola L.) fiber concentrate on lipid metabolism in mice. Int J Food Sci Nutr 65 (2014), 862–867.
71. [71] Chou, S.Y., Chien, P.J., Chau, C.F., Particle size reduction effectively enhances the cholesterol-lowering activities of carrots insoluble fiber and cellulose. J Agric Food Chem 56 (2008), 10994–10998.
72. [72] O'Shea, N., Arendt, E.K., Gallagher, E., Dietary fibre and phytochemical characteristics of fruit and vegetable by-products and their recent applications as novel ingredients in food products. Innov Food Sci Emerg Technol 16 (2012), 1–10.
73. [73] Basu, S.K., Thomas, J.E., Acharya, S.N., Prospects for growth in global nutraceutical and functional food markets: a Canadian perspective. Aust J Basic Appl Sci 1 (2007), 637–649.
74. [74] Law, M.R., Wald, N.J., Wu, T., Hackshaw, A., Bailey, A., Systematic underestimation of association between serum cholesterol concentration and ischaemic heart disease in observational studies: data from BUPA study. Br Med J 308 (1994), 363–366.
75. [75] Manson, J.E., Tosteson, H., Ridker, P.M., Satterield, S., Hebert, P., O'Connor, G.T., The primary prevention of myocardial infarction. N Engl J Med 326 (1992), 1406–1416.
76. [76] De Smet, I., De Boever, P., Verstraete, W., Cholesterol lowering in pigs through enhanced bacterial bile salt hydrolase activity. Br J Nutr 79 (1998), 185–194.
77. [77] Klaver, F.A., Meer, R.V.D., The assumed assimilation of cholesterol by lactobacilli and Bifidobacterium bifidum is due to their bile salt-deconjugating activity. Appl Environ Microbiol 59 (1993), 1120–1124.
78. [78] Pereira, D.I., Gibson, G.R., Effects of consumption of probiotics and prebiotics on serum lipid levels in humans. Crit Rev Biochem Mol Biol 37 (2002), 259–281.
79. [79] Assmann, G., Gotto, A.M. Jr., HDL cholesterol and protective factors in atherosclerosis. Circulation 109 (2004), III8–14.
80. [80] Hewawasam, R.P., Jayatilaka, K.A.P.W., Pathirana, C., Mudduwa, L.K.B., Hepatoprotective effect of Epaltes divaricata extract on carbon tetrachloride induced hepatotoxicity in mice. Ind J Med Res 120 (2004), 30–34.
81. [81] Halliwell, B., Gutteridge, J.M., Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol 186 (1990), 1–85.
82. [82] Tan, M., Schmidtm, R.H., Beier, J.I., Watson, W.H., Zhong, H., States, J.C., Arteel, G.E., Chronic subhepatotoxic exposure to arsenic enhances hepatic injury caused by high fat diet in mice. Toxicol Appl Pharmacol 257 (2011), 356–364.
83. [83] Song, H.Y., Mao, Z.M., Yang, L.L., Liu, T., Li, D.F., Zhang, L., Ge, Y.L., Zheng, P.Y., Liu, P., Zhang, X.Q., Ji, G., Dangfei liganning capsules attenuate the susceptibility of rat nonalcoholic fatty liver to carbon tetrachloride toxicity. J Tradit Chin Med 31:4 (2011 Dec), 327–333.
84. [84] Aly, N.H., Effect of dietary oat and wheat bran on biochemical changes in rats fed high fat-high cholesterol diets. J Appl Sci Res 8 (2012), 598–604.
85. [85] El Rabey, H.A., Al-Seeni, M.N., Amer, H.M., Efficiency of barley bran and oat bran in ameliorating blood lipid profile and the adverse histological changes in hypercholesterolemic male rats. BioMed Res Int, 2013, 2013, 263495.
86. [86] Muntner, P., Coresh, J., Smith, J.C., Eckfeldt, J., Klag, M.J., Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. Kidney Int 58 (2000), 293–301.
87. [87] Gervais, M., Pons, S., Nicoletti, A., Cosson, C., Giudicelli, J.F., Richer, C., Fluvastatin prevents renal dysfunction and vascular NO deficit in apolipoprotein E deficient mice. Arterioscler Thromb Vasc Biol 23 (2003), 183–189.